Abstract:Since the approval of the first checkpoint inhibitor, ipilimumab (α-CTLA4), there continues to be enthusiasm around leveraging the immune system to eradicate solid tumors. However, unknowns about the cellular mechanism(s) that cause some patients to durably respond while others relapse, continue to stymie the field. To support ongoing efforts elucidating cell subsets responsible for differences in patient responses, we aim to evaluate the functional heterogeneity of T-cell subsets responding to checkpoint inhibitors in mouse models of solid tumors. Single-cell RNA-seq has enabled discoveries of transcriptionally defined cell subsets, but understanding their function require inference from transcription, flow-based validation biased by pre-selection of subsets with specific markers, or reliance on surrogate markers for cell-extrinsic functions (e.g., cytotoxicity). Thus, functional heterogeneity could be obscured. To address this, we leveraged a novel technology that converges live, cellular functions with transcriptomics at the resolution of single cell-cell interactions. This technology captures tens of thousands of individual cells or defined combinations of groups of cells in bio-compatible hydrogel compartments, enabling longitudinal imaging over days to weeks. Throughout this period, functions are characterized via bright-field or immunofluorescence readouts, including antibodies, cytokine capture beads, and dyes. Cells are then lysed within compartments to generate barcoded libraries for mRNA-sequencing and gene signatures from individual cells computationally deconvoluted. With this technology, we developed a novel assay that enables longitudinal, unbiased functional characterization of individual T cells mapped to single-cell transcriptomics. Single mouse primary T cells were encapsulated with one or more MC38 target cells and imaged over time. We validated combinations of different readouts can be measured from the same T-cell, including cell-counts for proliferation, CD8/3 expression to differentiate T cells from target cells, activation markers, and / or target cell death via Sytox. Thus, single T cells can be multi-functionally evaluated over time, enabling the study of attributes inaccessible at high scale with prior technologies, including kinetics of killing or the number of target cells killed by a single T-cell. For assays combining cytotoxicity and surface receptors, we generated barcoded libraries from functionally characterized T cells for sequencing and developed an analytical pipeline that deconvolutes mRNA from single T cells mapped to their multi-functional profiles, to identify novel pathways that regulate anti-tumor functions. We will leverage this workflow to functionally characterize single T cells in tumor-bearing mice treated with checkpoint inhibitors and map the data to underlying transcriptomics. In doing so, we aim to discover functional subsets, potentially with identical transcriptional profiles, to support hypothesis generation around mechanisms governing anti-tumor efficacy of checkpoint inhibitors. Citation Format: Jacqueline Yee, Praveer Sharma, Yunmin Li, Isaac Thomas, Pier F Gherardini, Teresa Ai, Mostafa Ronaghi, Gary Schroth, Matthew H Spitzer. Novel workflow for characterizing T-cell functional heterogeneity in response to checkpoint inhibitors [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Tumor Immunology and Immunotherapy; 2024 Oct 18-21; Boston, MA. Philadelphia (PA): AACR; Cancer Immunol Res 2024;12(10 Suppl) nr A025.

Abstract 3976: Single-cell TCRɑ/β and TCRγ/δ immune receptor profiling and immunophenotyping using a 96-well plate sorted-cell approach

Abstract 3984: Full-length TCR and BCR repertoire analysis, integrated with mRNA and surface proteins characterization, in a tumor mouse model

Integrating T-cell Receptor and Transcriptome for Large-Scale Single-Cell Immune Profiling Analysis

Abstract A025: Novel workflow for characterizing T-cell functional heterogeneity in response to checkpoint inhibitors

Abstract 313: Benchmarking immune repertoire sequencing technologies

T-Cell-Based Platform for Functional Screening of T-Cell Receptors Identified in Single-Cell RNA Sequencing Data Sets of Tumor-Infiltrating T-Cells

Barcoding intracellular reverse transcription enables high-throughput phenotype-coupled T cell receptor analyses

Abstract 339: Universal synthetic TCR/BCR spike-in controls to evaluate immune receptor profiling assay and next-generation sequencing performance

Abstract 2762: Single-cell analysis of circulating neoantigen-reactive CD8+ T cells allows isolation of novel tumor reactive TCRs

Abstract PO1-25-06: Integrated analysis of single-cell RNA and VDJ-sequencing data to identify T cell marker expressed on antigen-specific T cells

Linking the T cell receptor to the single cell transcriptome in antigen‐specific human T cells

Rapid parallel reconstruction and specificity screening of hundreds of T cell receptors

Abstract LB289: Single-cell CRISPR screens at scale to understand T cell biology

Abstract 2062: Identification of functional MAIT-specific TCRs using MR1 dCODE Dextramer® reagents and evaluating antigen presentation

TIRTL-seq: Deep, quantitative, and affordable paired TCR repertoire sequencing

Abstract 4898: Highly accurate profiling of leukocyte composition from bulk peripheral blood with targeted digital cytometry

Abstract 78: Superior resolution of intracellular markers with CyTOF reveals greater functional diversity of human T cells

Rapid Cloning, Expression, and Functional Characterization of Paired Αβ and Γδ T-cell Receptor Chains from Single-Cell Analysis

Rapid Cloning, Expression, And Functional Characterization Of Paired Alpha Beta And Gamma Delta T-Cell Receptor Chains From Single-Cell Analysis

Abstract 1516: Large scale, transcriptome-based analysis of TCR clonality reveals functional immunity in non-small cell lung cancer

Abstract 16: CD4+ and CD8+ TCRαβ-deficient bioluminescent reporter T cells for screening and characterization of neoantigen-specific TCRs